Historical record - last NADAC publication: 3/20/2019

Product Information

AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3923 per EA under NDC 43386008303. Its NADAC has been published 204 times since May 13, 2015.

The High Outlier badge above means this manufacturer's average price in the Amlodipine and Valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AMLODIPINE-VALSARTAN 5-160 MG

Amlodipine and Valsartan
$0.3923per EA
High Outlier

Strength

5; 160 mg/1; mg/1

NDC

43386008303

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

3/20/2019

Approval Type

Generic (ANDA)

FDA Application

ANDA202829

On Market Since

3/30/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 204 times since May 13, 2015, and over the history we have for it it has declined 90.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3923 per EA
All-time high$4.2444 (Jun 10, 2015)
All-time low$0.3625 (Dec 19, 2018)
Median price$0.4654
Average price$0.5874
Largest weekly change-66.9% (Jul 22, 2015)
Weeks tracked204
Tracking sinceMay 13, 2015

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-90.7%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.3923 per EA (NDC 43386008303), effective Apr 3, 2019.

How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 90.7%. It has been tracked across 204 weekly CMS publications since May 13, 2015.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?

Since May 13, 2015, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.3625 (Dec 19, 2018) to a high of $4.2444 (Jun 10, 2015), with a median of $0.4654 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, AMLODIPINE-VALSARTAN 5-160 MG, is $0.3721 per EA — about 5% below AMLODIPINE-VALSARTAN 5-160 MG.

Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?

AMLODIPINE-VALSARTAN 5-160 MG (NDC 43386008303) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.